We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Aesthetics and Reconstructive Surgery: A Market in Transformation
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Aesthetics and Reconstructive Surgery: A Market in Transformation
BusinessFinanceMedical DevicesMedical InnovationsTechnology

Aesthetics and Reconstructive Surgery: A Market in Transformation

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
reconstructive surgery market
SHARE

Aesthetic and reconstructive surgery has been undergoing a transformation over the past ten years. A wide range of forces are changing the dynamics of clinical practice and the market for products used. The drivers and limiters behind this have been and, to some degree, will continue to be:

Aesthetic and reconstructive surgery has been undergoing a transformation over the past ten years. A wide range of forces are changing the dynamics of clinical practice and the market for products used. The drivers and limiters behind this have been and, to some degree, will continue to be:

  • Aesthetic or purely cosmetic procedures are growing among all demographics (male/female, old/young).
  • The economic hits of the 2008 recession were severe, especially for aesthetics, but have begun to be replaced by new procedure volumes.
  • Aesthetics have become a more complex clinical practice employing surgery, a wide range of implant types and materials, topicals and physician driven procedures.
  • Reconstructive medicine has advanced through developments in autologous tissue engineering, extracellular matrices, and other technologies that address bone defects and other orthomusucloskeletal problems.
  • The advances in reconstructive medicine have begun to trickle-down to aesthetic procedures, stimulating increasingly volume of cosmetic procedures paid out-of-pocket.

There has been a series of shifts in aesthetics/reconstruction procedure volumes commensurate with these and other forces. The result is a wide swing in procedure volumes over the past decade, much of which is expected to continue. See the table below.

Percent Change in Aesthetic/Reconstructive Procedures, 2002 to 2012

More Read

My Perspective on the High Cost of Cancer Drugs
Nurses Using BlackBerrys at the Hospital for Communication and Patient Care (Video)
Digital Health Summit: Should it be Advancing or Aligning Innovation?
Doctors and Nurses: Doctors need to Order Less, Listen More
Facility Fees For Office Visits: What is the Role of Health Plans?

reconstructive surgery market

Source: MedMarket Diligence, LLC; Report #S710.

Other forces behind transformation in aesthetics and reconstruction are fundamental advances in cell biology, continued progress in biomaterials development, advances in wound sealants, glues and wound closure, and others.


The topics in this post are the subject of the comprehensive MedMarket Diligence report, “Global Markets for Products and Technologies in Aesthetic and Reconstructive Surgery, 2013-2018.” See link for further details.

Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: The article's core relationship is that substantial clinical testing of thymosin alpha-1 did not est
Thymosin Alpha-1 Got the Big Trials Most Peptides Never Get
Global Healthcare
October 12, 2026
Flat editorial illustration: The article examines how researchers study tissue repair through growth factors and peptide-based re
How Researchers Study Tissue Repair: From Growth Factors to Peptide-Based Research
Health
October 12, 2026
Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026
The Case for Proactive Nutrient Support and Where IV Therapy Fits In -- AI-generated illustration
The Case for Proactive Nutrient Support and Where IV Therapy Fits In
Health Therapies
October 5, 2026

You Might also Like

top 7 icd10 resources
BusinessHospital AdministrationPolicy & Law

The Top 7 ICD-10 Implementation Resources

January 6, 2014

Can a Blood Test Really Tell You When You’ll Die?

October 18, 2011

Is Medicaid Cheaper and Better than Private Insurance?

January 27, 2012

Up Next for Care-Hacking Startups: Transforming Data into Action

February 24, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?